The tumor cells from both sexes had similar transcript levels of estrogen receptor alpha (Esr1), androgen receptor (Ar), and human epidermal growth factor receptors (Erbb2, Erbb3), which are the attributes of the Luminal B breast cancer subtype. Here, ERBB2 is linked to neoplasm.